Literature DB >> 6092669

Characterization of the guinea pig cytomegalovirus genome by molecular cloning and physical mapping.

M Gao, H C Isom.   

Abstract

Fragments of guinea pig cytomegalovirus (GPCMV) DNA produced by HindIII or EcoRI restriction endonuclease digestion were cloned into vectors pBR322 and pACYC184, and recombinant fragments representing ca. 97% of the genome were constructed. Hybridization of 32P-labeled cloned and gel-purified HindIII, EcoRI, and XbaI fragments to Southern blots of HindIII-, EcoRI-, and XbaI-cleaved GPCMV DNA verified the viral origin of cloned fragments and allowed construction of HindIII, EcoRI, and XbaI restriction maps. On the basis of the cloning and mapping experiments, the size of GPCMV DNA was calculated to include 239 kilobase pairs, corresponding to a molecular weight of 158 X 10(6). No cross-hybridization between any internal fragments was seen. We conclude that the GPCMV genome consists of a long unique sequence with terminal repeat sequences but without internal repeat regions. In addition, GPCMV DNA molecules exist in two forms. In the predominant form, the molecules demonstrate sequence homology between the terminal fragments; in the minor population, one terminal fragment is smaller by 0.7 X 10(6) daltons and is not homologous with the fragment at the other end of the physical map. The structural organization of GPCMV DNA is unique for a herpesvirus DNA, similar in its simplicity to the structure reported for murine cytomegalovirus DNA and quite dissimilar from that of human cytomegalovirus DNA.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092669      PMCID: PMC254544     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  70 in total

1.  The structure of the termini of the DNA of Epstein-Barr virus.

Authors:  C R Kintner; B Sugden
Journal:  Cell       Date:  1979-07       Impact factor: 41.582

Review 2.  The structure and isomerization of herpes simplex virus genomes.

Authors:  B Roizman
Journal:  Cell       Date:  1979-03       Impact factor: 41.582

3.  Analysis of the structure of the genome of pseudorabies virus.

Authors:  T Ben-Porat; F J Rixon; M L Blankenship
Journal:  Virology       Date:  1979-06       Impact factor: 3.616

4.  Size and complexity of human cytomegalovirus DNA.

Authors:  J M DeMarchi; M L Blankenship; G D Brown; A S Kaplan
Journal:  Virology       Date:  1978-09       Impact factor: 3.616

5.  Activation of latent murine cytomegalovirus infection: cocultivation, cell transfer, and the effect of immunosuppression.

Authors:  D Mayo; J A Armstrong; M Ho
Journal:  J Infect Dis       Date:  1978-12       Impact factor: 5.226

6.  Synergistic infection with murine cytomegalovirus and Pseudomonas aeruginosa in mice.

Authors:  J R Hamilton; J C Overall
Journal:  J Infect Dis       Date:  1978-06       Impact factor: 5.226

7.  Human cytomegalovirus DNA. I. Molecular weight and infectivity.

Authors:  J L Geelen; C Walig; P Wertheim; J van der Noordaa
Journal:  J Virol       Date:  1978-06       Impact factor: 5.103

8.  Experimental congenital infection with cytomegalovirus: a guinea pig model.

Authors:  M L Kumar; G A Nankervis
Journal:  J Infect Dis       Date:  1978-11       Impact factor: 5.226

9.  Cytomegalovirus infection in guinea pigs. I. Viremia during acute primary and chronic persistent infection.

Authors:  G D Hsiung; Y C Choi; F Bia
Journal:  J Infect Dis       Date:  1978-08       Impact factor: 5.226

10.  Cytomegalovirus infection in guinea pigs. II. Transplacental and horizontal transmission.

Authors:  Y C Choi; G D Hsiung
Journal:  J Infect Dis       Date:  1978-08       Impact factor: 5.226

View more
  23 in total

1.  The ends on herpesvirus DNA replicative concatemers contain pac2 cis cleavage/packaging elements and their formation is controlled by terminal cis sequences.

Authors:  M A McVoy; D E Nixon; J K Hur; S P Adler
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Molecular characterization of the guinea pig cytomegalovirus UL83 (pp65) protein homolog.

Authors:  M R Schleiss; A McGregor; N J Jensen; G Erdem; L Aktan
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

3.  Guinea pig cytomegalovirus GP84 is a functional homolog of the human cytomegalovirus (HCMV) UL84 gene that can complement for the loss of UL84 in a chimeric HCMV.

Authors:  A McGregor; K Y Choi; M R Schleiss
Journal:  Virology       Date:  2010-11-20       Impact factor: 3.616

Review 4.  Animal cytomegaloviruses.

Authors:  J Staczek
Journal:  Microbiol Rev       Date:  1990-09

5.  Identification and characterization of the guinea-pig cytomegalovirus glycoprotein H gene.

Authors:  R C Brady; M R Schleiss
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

6.  Circularization and cleavage of guinea pig cytomegalovirus genomes.

Authors:  M A McVoy; D E Nixon; S P Adler
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

7.  Sequence and transcriptional analysis of the guinea pig cytomegalovirus UL97 homolog.

Authors:  D S Fox; M R Schleiss
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

8.  Molecular, biological, and in vivo characterization of the guinea pig cytomegalovirus (CMV) homologs of the human CMV matrix proteins pp71 (UL82) and pp65 (UL83).

Authors:  Alistair McGregor; Fenyong Liu; Mark R Schleiss
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Cloning the complete guinea pig cytomegalovirus genome as an infectious bacterial artificial chromosome with excisable origin of replication.

Authors:  Xiaohong Cui; Alistair McGregor; Mark R Schleiss; Michael A McVoy
Journal:  J Virol Methods       Date:  2008-03-24       Impact factor: 2.014

10.  Localization of the human cytomegalovirus 2.7-kb major early beta-gene transcripts by RNA in situ hybridization in permissive and nonpermissive infections.

Authors:  T C Wu; W A Lee; M C Pizzorno; W C Au; Y J Chan; R H Hruban; G M Hutchins; G S Hayward
Journal:  Am J Pathol       Date:  1992-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.